Last reviewed · How we verify

NCT04901767: SPARTAN-VM

Coronary Artery Endothelial Dysfunction With Drug Coated Balloons

Completed Last updated 21 December 2023
What this trial tests

trial in Coronary Artery Disease in 14 participants. Completed in 1 February 2022.

Timeline
23 March 2021
Primary endpoint
1 February 2022
1 February 2022

Quick facts

Lead sponsorNorfolk and Norwich University Hospitals NHS Foundation Trust
StatusCompleted
Study typeOBSERVATIONAL
Enrollment14
Start date23 March 2021
Primary completion1 February 2022
Estimated completion1 February 2022
Sites1 location across United Kingdom

Conditions studied

Sponsor

Norfolk and Norwich University Hospitals NHS Foundation Trust

Who can join

18 and older, any sex, with Coronary Artery Disease or Ischaemic Heart Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Use of intracoronary acetylcholine to investigate endothelial function in coronary arteries treated with either drug coated balloon angioplasty of drug eluting stents.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Coronary Artery Disease

Currently open trials in the same condition.

Other Norfolk and Norwich University Hospitals NHS Foundation Trust trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04901767.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing